首页 | 本学科首页   官方微博 | 高级检索  
     


Tularemia vaccine: past,present and future
Authors:Petra C.F.?Oyston  author-information"  >  author-information__contact u-icon-before"  >  mailto:pcoyston@dstl.gov.uk"   title="  pcoyston@dstl.gov.uk"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Janine E.?Quarry
Affiliation:(1) Defence Science and Technology Laboratories, SP4 0JQ Porton Down, Salisbury, Wiltshire
Abstract:Francisella tularensis is a Gram negative intracellular pathogen that causes the highly debilitating or fatal disease tularemia. F. tularensis can infect a wide range of animals and can be transmitted to humans in a variety of ways, the most common being by the bite of an infected insect or arthropod vector. The attenuated F. tularensis live vaccine strain (LVS) has been used previously under investigational new drug status to vaccinate at-risk individuals. However the history of the strain and lack of knowledge regarding the basis of attenuation has so far prevented its licensing. Therefore the focus of current research is on producing a new vaccine against tularemia that would be suitable for licensing.
Keywords:Tularemia  Vaccine
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号